Considering Antiviral Treatment to Preserve Hearing in Congenital CMV
Authors:
- 25 January 2023
- journal article
- research article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 151 (2)
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Changes in Valganciclovir Use Among Infants with Congenital Cytomegalovirus Diagnosis in the United States, 2009-2015 and 2016-2019The Journal of Pediatrics, 2022
- The Effect of (Val)ganciclovir on Hearing in Congenital Cytomegalovirus: A Systematic ReviewThe Laryngoscope, 2022
- Progressive, Long-Term Hearing Loss in Congenital CMV Disease After Ganciclovir TherapyJournal of the Pediatric Infectious Diseases Society, 2021
- Hematologic Adverse Events Associated With Prolonged Valganciclovir Treatment in Congenital Cytomegalovirus InfectionThe Pediatric Infectious Disease Journal, 2019
- Congenital CytomegalovirusThe Pediatric Infectious Disease Journal, 2017
- Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapyThe Lancet Infectious Diseases, 2017
- Valganciclovir for Congenital CytomegalovirusNew England Journal of Medicine, 2015
- Valganciclovir for Symptomatic Congenital Cytomegalovirus DiseaseNew England Journal of Medicine, 2015
- Cochlear implants in children deafened by congenital cytomegalovirus and matched Connexin 26 peersInternational Journal of Pediatric Otorhinolaryngology, 2014
- Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trialThe Journal of Pediatrics, 2003